Fig. 4From: Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysisThe forest plots of secondary outcomes: a clinical response; b microbiological response; c Length of stay in hospital; d Adverse events. Studies were ranked according to their effect sizes. #Ampicillin–sulbactam was used in non-polymyxins groupBack to article page